Role of i.v. allopurinol and rasburicase in tumor lysis syndrome
Author information unavailable
Abstract
Author information unavailable
Abstract
Journal Article Role of i.v. allopurinol and rasburicase in tumor lysis syndrome Get access American Journal of Health-System Pharmacy, Volume 60, Issue 21, 1 November 2003, Pages 2223–2224, https://doi.org/10.1093/ajhp/60.21.2223 Published: 01 November 2003
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Journal Article Role of i.v. allopurinol and rasburicase in tumor lysis syndrome Get access American Journal of Health-System Pharmacy, Volume 60, Issue 21, 1 November 2003, Pages 2223–2224, https://doi.org/10.1093/ajhp/60.21.2223 Published: 01 November 2003
Key concepts: Rasburicase, Tumor lysis syndrome, Allopurinol, Lysis, Pharmacy, Medicine, Internal medicine, Oncology